NCT07213141View on ClinicalTrials.gov

Incidence of Graves' Disease After COVID-19 Vaccination

Active, not recruitingOBSERVATIONAL

Enrollment

161

Participants

Timeline

Start Date

November 8, 2022

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Graves Disease

Interventions

OTHER

Data extraction

Data extraction from medical records

Trial Locations (3)

1000

CHU St Pierre, Brussels

1020

CHU Brugmann, Brussels

1090

UZ Brussel, Jette

All Listed Sponsors

lead

Laura ICONARU

OTHER